The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
2022
DOI: 10.3390/life12010068
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of Three Automated Extraction Systems for the Detection of SARS-CoV-2 from Clinical Respiratory Specimens

Abstract: Severe acute respiratory syndrome coronavirus (SARS-CoV-2) is highly contagious and causes coronavirus disease 2019 (COVID-19). Reverse transcription quantitative polymerase chain reaction (RT-qPCR) is the most accurate and reliable molecular assay to detect active SARS-CoV-2 infection. However, a rapid increase in test subjects has created a global bottleneck in testing capacity. Given that efficient nucleic acid extraction greatly affects reliable and accurate testing results, we compared three extraction pl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
15
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 15 publications
(20 citation statements)
references
References 33 publications
1
15
0
Order By: Relevance
“…It demonstrated a sensitivity of 100 % compared to the reference laboratory method and viral detection down to 2.80 copies μl −1 (2800 copies ml –1 ) [9]. There are a range of other well-established commercial extraction platforms used in pathogen diagnostics for the molecular detection of SARS-CoV-2 in respiratory samples, and all of the major commercial methods tested have been found to have good agreement, with recommendations that they could be interchanged [10–13]. The difficulties experienced worldwide in procuring laboratory equipment and reagents have necessitated diagnostic microbiology laboratories to explore other extraction and testing platforms on the market.…”
Section: Discussionmentioning
confidence: 99%
“…It demonstrated a sensitivity of 100 % compared to the reference laboratory method and viral detection down to 2.80 copies μl −1 (2800 copies ml –1 ) [9]. There are a range of other well-established commercial extraction platforms used in pathogen diagnostics for the molecular detection of SARS-CoV-2 in respiratory samples, and all of the major commercial methods tested have been found to have good agreement, with recommendations that they could be interchanged [10–13]. The difficulties experienced worldwide in procuring laboratory equipment and reagents have necessitated diagnostic microbiology laboratories to explore other extraction and testing platforms on the market.…”
Section: Discussionmentioning
confidence: 99%
“…Based on the collection site, ALLTM and SELTM universal transport media were classified into two sets of swabs. Nucleic acids were simultaneously extracted from HCW- and self-collected specimens using the automated MagNA Pure 96 system (Roche, Inc., Basel, Switzerland), as described previously [ 23 ]. Following the Pathogen Universal 200 protocol, 200 µL of the samples was processed using magnetic beads for nucleic acid extraction.…”
Section: Methodsmentioning
confidence: 99%
“…Three SARS-CoV-2-positive samples were selected for stability assessment, and 72 vials of additional samples were prepared in each medium. All samples were processed using an automated nucleic acid extraction system (MagNA Pure 96; Roche, Basel, Switzerland), in accordance with the “Pathogen Universal 200” protocol described in a previous study [ 21 ]. In brief, the MagNA Pure 96 DNA and Viral NA Small Volume kit (Roche) was used, and 200 μ L of each sample was transferred to the cartridge.…”
Section: Methodsmentioning
confidence: 99%
“…In addition, we compared the three media to evaluate the stability of incubation conditions and storage duration. [21].…”
Section: Introductionmentioning
confidence: 99%